Monograph Series on Aging-related Diseases: XI. Glaucoma

Chronic Diseases in Canada

Volumn 19, Issue 4, 1998, Pages 157-169

  Elolia, Robin ^a   Stokes, Julie ^a,b  

^a Health Promotion and Programs Branch   (Canada)

^b LAB CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

Diagnosis; Glaucoma; Morbidity; Risk factors; Screening; Treatment

Indexed keywords

AGE; AGE DISTRIBUTION; AGED; AGING; BLINDNESS; CANADA; FEMALE; GLAUCOMA; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PREVALENCE; REVIEW; RISK FACTOR;

AGE DISTRIBUTION; AGE FACTORS; AGED; AGING; BLINDNESS; CANADA; FEMALE; GLAUCOMA; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 0032250495     PISSN: 02288699     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (121)

1. Cahill M. Professional guide to diseases. 5th ed. Springhouse (PA): Springhouse Corporation, 1995:1185.
2. Newell FW. Ophthalmology principles and concepts. St Louis (MI): Mosby, 1992:368.
3. World Health Organization. The world health report 1997. Conquering suffering, enriching humanity. Geneva: WHO, 1997:68.
4. Mains V. CNIB client statistics. Canadian National Institute for the Blind, 1995.
5. Patterson C. Screening for visual impairment in the elderly. In: Canadian Task Force on the Periodic Health Examination. The Canadian guide to clinical preventive health care. Ottawa, 1994; Health Canada Cat H21-117/1994E:932-42.
6. Anonymous. Vision and your eyes. Managing common problems. Suppl to Mayo Clinic Health Letter 1995:1-8.
7. Hoskins HD Jr, Kass MA. Becker-Shaffer's diagnosis and therapy of the glaucomas. St Louis (MI): CV Mosby Co, 1989.
8. Boyd-Monk H, Steimmetz CG. Nursing care of the eye. Norwalk (CT): Appleton Lange, 1987:323.
9. Alexander LJ. Diagnosis and management of primary open-angle glaucoma. Optom Clin 1991;1:19-102.
10. Leske MC. The epidemiology of open-angle glaucoma: a review. Am J Epidemiol 1983;118:166-91.
11. Jay JL. Primary open-angle glaucoma. Practitioner 1992;236:199-202.
12. Abyad A. In-office screening for age-related hearing and vision loss. Geriatrics 1997;52:45-57.
13. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthal 1996;80:389-93.
14. Wormald RP, Rauf A. Glaucoma screening. J Med Screen 1995;2:109-14.
15. Grant WM, Burke JF. Why do some people go blind from glaucoma? Ophthalmology 1982;89:991-8.
16. Coffey M, Reidy A, Wormald R, Xian WX, Wright L, Courtney P. Prevalence of glaucoma in the west of Ireland. Br J Ophthalmol 1993;77:17-21.
17. Foster PJ, Baasanhu J, Alsbirk PH, Munkhbayar D, Uranchimeg D, Johnson GJ. Glaucoma in Mongolia: a population-based survey in Hovsgol Province, Northern Mongolia. Arch Ophthalmol 1996;114:1235-41.
18. Sommer A, Tielsch JM, Katz J, et al. Racial differences in the cause-specific prevalence of blindness in East Baltimore. N Engl J Med 1991;325:1412-7.
19. Hiller R, Kahn HA. Blindness from glaucoma. Am J Ophthalmol 1975;80:62-9.
20. Rosenberg LF. Glaucoma: early detection and therapy for prevention of vision loss. Am Fam Physician 1995;52:2289-98, 2303-4.
21. Marshall EC. Racial differences in the presentation of chronic open-angle glaucoma. J Am Optom Assoc 1989;60:760-7.
22. Kahn HA, Milton RC. Alternative definitions of open-angle glaucoma. Effect on prevalence and associations in the Framingham Eye Study. Arch Opthalmol 1980;98:2172-7.
23. Giuffre G, Giammanco R, Dardanoni G, Ponte F. Prevalence of glaucoma and distribution of intraocular pressure in a population. The Casteldaccia Eye Study. Acta Ophthalmol Scand 1995;73:222-5.
24. Cedrone C, Culasso F, Cesareo M, Zapelloni A, Cedrone P, Cerulli L. Prevalence of glaucoma in Ponza, Italy: a comparison with other studies. Ophthalmic Epidemiol 1997;4:59-72.
25. Klein BE, Klein R, Sponsel WE, et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology 1992;99:1499-504.
26. Tielsch JM, Katz J, Singh K, et al. A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am J Epidemiol 1991;134:1102-10.
27. Tielsch JM, Katz J, Quigley HA, Javitt JC, Sommer A. Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology 1995;102:48-53.
28. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 1991;266:369-74.
29. Leske MC, Connell AM, Schachat AP, Hyman L. The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol 1994;112:821-9.
30. Mason RP, Omofolasade K, Wilson MR, et al. National survey of the prevalence and risk factors of glaucoma in St. Lucia, West Indies. Part I: prevalence findings. Ophthalmology 1989;96:1363-8.
31. Shiose Y, Kitazawa Y, Tsukahara S, et al. Epidemiology of glaucoma in Japan - a nationwide glaucoma survey. Jpn JOphthalmol 1991;35:133-55.
32. Salmon JF, Mermoud A, Ivey A, Swanevelder SA, Hoffman M. The prevalence of primary angle-closure glaucoma and open angle glaucoma in Mamre, western Cape, South Africa. Arch Ophthalmol 1993;111:1263-9.
33. Mitchell P, Smith W, Attebo K, Healey PR. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 1996;103:1661-9.
34. Kini MM, Leibowitz HM, Colton T, Nickerson RJ, Gangley J, Dawber TR. Prevalence of senile cataract, diabetic retinopathy, senile macular degeneration, and open-angle glaucoma in the Framingham Eye Study. Am J Ophthalmol 1978;85:28-34.
35. Leske MC, Connell AM, Wu SY, Hyman LG, Schachat AP. Risk factors for open-angle glaucoma. The Barbados Eye Study. Arch Ophthalmol 1995;113:918-24.
36. Wilensky JT, Gandhi N, Pan T. Racial influences in open-angle glaucoma. Ann Ophthalmol 1978;10:1398-402.
37. Coulehan JL, Helzlsouer KJ, Rogers KD, Brown SI. Racial differences in intraocular tension and glaucoma surgery. Am J Epidemiol 1980;111:759-68.
38. Hiller R, Sperduto RD, Krueger DE. Race, iris pigmentation, and intraocular pressure. Am J Epidemiol 1982;115:674-83.
39. Seddon JM, Schwartz B, Flowerdew G. Case-control study of ocular hypertension. Arch Ophthalmol 1983;101:891-4.
40. David R, Livingston D, Luntz MH. Ocular hypertension: a comparative follow up of black and white patients. Br J Ophthalmol 1978;62:676-8.
41. Martin MJ, Sommer A, Gold E, Diamond EL. Race and primary open-angle glaucoma. Am J Ophthalmol 1985;99:383-7.
42. Leske MC, Connell AM, Wu SY, Hyman L, Schachat AP. Distribution of intraocular pressure. The Barbados Eye Study. Arch Ophthalmol 1997;115:1051-7.
43. Rosenthal AR, Perkins ES. Family studies in glaucoma. Br J Ophthalmol 1985;69:664-7.
44. Perkins ES. Family studies in glaucoma. Br J Ophthalmol 1974;58:529-35.
45. Morgan RW, Drance SM. Chronic open-angle glaucoma and ocular hypertension: an epidemiological study. Br J Ophthalmol 1975;59:211-5.
46. Shin DH, Becker B, Kolker AE. Family history in primary open-angle glaucoma. Arch Ophthalmol 1977;95:598-600.
47. Uhm KB, Shin DH. Positive family history of glaucoma is a risk factor for increased IOP rather than glaucomatous optic nerve damage (POAG vs OH vs normal control). Korean J Ophthalmol 1992;6:100-4.
48. Vernon SA. Screening siblings for glaucoma in the UK. J R Soc Med 1991;84:545-6.
49. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Family history and risk of primary open angle glaucoma. The Baltimore Eye Survey. Arch Ophthalmol 1994;112:69-73.
50. Armaly MF. Genetic determination of cup-to-disc ratio of the optic nerve. Arch Ophthalmol 1967;78:35-45.
51. Armaly MF. The genetic determination of ocular pressure in the normal eye. Arch Ophthalmol 1967;78:187-92.
52. Leske MC, Warheit-Roberts L, Wu SY. Open-angle glaucoma and ocular hypertension: the Long Island Glaucoma Case-control Study. Ophthalmic Epidemiol 1996;3:85-96.
53. Brezin AP, Bechetoille A, Hamard P, et al. Genetic heterogeneity of primary open angle glaucoma and ocular hypertension: linkage to GLC1A associated with an increased risk of severe glaucomatous optic neuropathy. J Med Genet 1997;34:546-52.
54. Stone EM, Fingert JH, Alward WLM, et al. Identification of a gene that causes primary open angle glaucoma. Science 1997;275:668-70.
55. Morissette J, Cote G, Anctil JL, et al. A common gene for juvenile and adult-onset primary open-angle glaucomas confined on chromosome 1q. Am J Hum Genet 1995;56:1431-42.
56. Liu S, Cheung JC, Heon E. The genetics of glaucoma: an update. Can J Ophthalmol 1997;32:221-8.
57. Katz J, Sommer A. Risk factors for primary open angle glaucoma. Am J Prev Med 1988;4:110-4.
58. Zeiter JH, Shin DH, Baek NH. Visual field defects in diabetic patients with primary open-angle glaucoma. Am J Ophthalmol 1991;111:581-4.
59. Heijl A, Lundquist L. The frequency distributions of earliest glaucomatous visual field defects documented by automatic perimetry. Acta Ophthalmol 1983;62:658.
60. Wilson MR, Hertzmark E, Walker AM, et al. A case-control study of risk factors in open-angle glaucoma. Arch Ophthalmol 1987;105:1066-71.
61. Reynolds DC. Relative risk factors in chronic open-angle glaucoma: an epidemiological study. Am J Optom Physiol Opt 1977;54:116-20.
62. Mapstone R, Clark CV. The prevalence of autonomie neuropathy in glaucoma. Trans Ophthalmol Soc U K 1985;104:265-9.
63. Kahn HA, Leibowitz HM, Gangley J, et al. The Framingham Eye Study. I: Outline and major prevalence findings. Am J Epidemiol 1977;106:17-32.
64. Quigley HA, Enger C, Katz J, et al. Risk factors for the development of glaucomatous visual field loss in ocular hypertension. Arch Ophthalmol 1994;112:644-9.
65. Wormald RP, Basauri E, Wright LA, Evans JR. The African-Caribbean Eye Survey: risk factors for glaucoma in a sample of African Caribbean people living in London. Eye 1994;8:315-20.
66. Ponte F, Giuffre G, Giammanco R, Dardanoni G. Risk factors of ocular hypertension and glaucoma. The Casteldaccia Eye Study. Doc Ophthalmol 1994;85:203-10.
67. Klein BE, Klein R, Jensen SC. Open-angle glaucoma and older-onset diabetes. The Beaver Dam Eye Study. Ophthalmology 1994;101:1173-7.
68. Mitchell P, Smith W, Chey T, Healey PR. Open-angle glaucoma and diabetes. The Blue Mountains Eye Study, Australia. Ophthalmology 1997;104:712-8.
69. Becker B. Diabetes mellitus and primary open-angle glaucoma. Am J Ophthalmol 1971;71:1-6.
70. Leske MD, Podgor MJ. Intraocular pressure, cardiovascular risk variables and visual field defects. Am J Epidemiol 1983;118:280-7.
71. Klein BEK, Klein R, Moss SE. Intraocular pressure in diabetic persons. Ophthalmology 1984;91:1356-60.
72. Ellenberger C Jr. Ischemic optic neuropathy as a possible early complication of vascular hypertension. Am J Ophthalmol 1979;88:1045-51.
73. Klein BE, Klein R. Intraocular pressure and cardiovascular risk variables. Arch Ophthalmol 1981;99:837-9.
74. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JG. Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol 1995;113:216-21.
75. DeBlasio PF Jr. Brasch PC. Minor blood loss as a cause for normal tension "glaucomatous" optic neuropathy. R I Med 1994;77:45-6.
76. Phelps CD, Corbett JJ. Migraine and low-tension glaucoma. A case-control study. Invest Ophthalmol Vis Sci 1985;26:1105-8.
77. Klein BE, Klein R, Meuer SM, Goetz LA. Migraine headache and its association with open-angle glaucoma: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 1993;34:3024-7.
78. Usui T, Iwata K, Shirakashi M, Abe H. Prevalence of migraine in low-tension glaucoma and primary open-angle glaucoma in Japanese. Br J Ophthalmol 1991;75:224-6.
79. Klein BE, Klein R, Ritter LL. Relationship of drinking alcohol and smoking to prevalence of open-angle glaucoma. The Beaver Dam Eye Study. Ophthalmology 1993;100:1609-13.
80. Schwartz B. The response of ocular pressure to corticosteroids. Int Ophthalmol Clin 1966;6:929-45.
81. Becker B, Hahn KA. Topical corticosteroids in heredity in primary open-angle glaucoma. Am J Ophthalmol 1964;57:543-51.
82. Garbe E, LeLorier J, Boivin J, Suissa S. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA 1997;277:722-7.
83. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans: the Baltimore Eye Survey. Arch Ophthalmol 1991;109:1090-5.
84. Sponsel WE. Tonometry in question: can visual screening tests play a more decisive role in glaucoma diagnosis and management. Surv Ophthalmol 1989;33:291-300.
85. Schappert-Kemmijser J. A five-year follow-up of subjects with IOP of 22-30 mmHg without glaucoma at first investigation. Ophthalmologica 1971;162:289-95.
86. Tomlinson A, Phillips CI. Ratio of optic cup to optic disc. Br J Ophthalmol 1969;53:758-65.
87. Chi T, Ritch R, Strickler D, et al. Racial differences in optic nerve head parameters. Arch Ophthalmol 1989;107:836-9.
88. Armaly MF. Optic cup in normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 1970;9:425-9.
89. Jonas JB, Fernandez MC, Naumann GO. Correlation of the optic disc size to glaucoma susceptibility. Ophthalmology 1991;98:675-80.
90. Mastropasqua L, Lobefalo L, Mancini A, Ciancaglini M, Palma S. Prevalence of myopia in open angle glaucoma. Eur J Ophthalmol 1992;2:33-5.
91. Chihara E, Liu X, Dong J, et al. Severe myopia as a risk factor for progressive visual field loss in primary open-angle glaucoma. Ophthalmologica 1997;211:66-71.
92. Erie JC, Hodge DO, Gray DT. The incidence of primary angle-closure glaucoma in Olmsted County, Minnesota. Arch Ophthalmol 1997;115:177-81.
93. Yu Q, Xu J, Zhu S, Liu Q. Epidemiological survey of primary angle-closure glaucoma in Doumen. Yen Ko Hsueh Pao 1995;11:5-8.
94. Arkell SM, Lightman DA, Sommer A, et al. The prevalence of glaucoma among Eskimos of NW Alaska. Arch Ophthalmol 1987;105:482-5.
95. Alsbirk PH. Anterior chamber depth, genes and environment. Acta Ophthalmol 1982;60:223-34.
96. Alsbirk PH. Early detection of primary angle-closure glaucoma: limbal and axial chamber-depth screening in a high-risk population (Greenland Eskimos). Acta Ophthalmol 1988;66:556-64.
97. Congdon N, Wang F, Tielsch JM. Issues in the epidemiology and population-based screening of primary angle-closure glaucoma. Surv Ophthalmol 1992;36:411-23.
98. van Rens GHMB, Arkell SM, Charlton W, Doesburg W. Primary angle-closure glaucoma among Alaskan Eskimos. Documenta Ophthalmologica 1988;70:265-76.
99. Nguyen N, Mora JS, Gaffney MM, et al. A high prevalence of occludable angles in a Vietnamese population. Ophthalmology 1996;103:1426-31.
100. Lowe RF. Causes of shallow anterior chamber in primary angle-closure glaucoma. Am J Ophthalmol 1969;67:89-93.
101. Salmon JF, Martell R. The role of ethnicity in primary angle-closure glaucoma. S Afr Med J 1994;84:623-6.
102. Alsbirk PH, Forsius H. Anterior chamber depths in Eskimos from Greenland, Canada (Igloolik) and Alaska (Wainwright). Arctic Ophthalmology Symposium 1973. Can J Ophthalmol 1973;8:265-9.
103. Drance SM, Morgan RW, Bryett J, Fairclough M. Anterior chamber depths and gonioscopic findings among Eskimos and Indians in the Canadian Arctic. Arctic Ophthalmology Symposium 1973. Can J Ophthalmol 1973;8:255-9.
104. Alsbirk PH. Primary angle-closure glaucoma: oculometry, epidemiology and genetics in a high-risk population. Acta Ophthalmol 1976;54:-31.
105. Teikari JM, O'Donnell J, Nurminen M, Raivio I. Acute closed angle glaucoma and sunshine. J Epidemiol Community Health 1991;45:291-3.
106. Leibowitz HM, Kreuger DE, Maunder IR, et al. The Framingham Eye Study monograph. Surv Ophthalmol 1980;24:335-610.
107. Tornquist R. Shallow anterior chambers in acute glaucoma. Acta Ophthalmol 1953;31:1-74.
108. Kitazawa Y. Epidemiology of PACG. Asian Pac J Ophthalmol 1990;2:78-81.
109. Booth B. Information nurses need to tell patients about glaucoma. Nursing Times 1994;90:39-41.
110. Dielemans I, Vingerling JR, Hofman A, Grobbee DE, de Jong PT. Reliability of intraocular pressure measurement with the Goldmann applanation tonometer in epidemiological studies. Graefes Arch Clin Exp Ophthalmol 1994;232:141-4.
111. Wood CM, Bosanquet RC. Limitations of direct ophthalmoscopy in screening for glaucoma. Br Med J 1987;294:1587-8.
112. Quigley HA, Katz J, Derrick RJ, Gilbert D, Sommer A. An evaluation of optic disc and nerve fiber layer examinations in monitoring progression of early glaucoma damage. Ophthalmology 1992;99:1928.
113. Sommer A, Katz J, Quigley HA, et al. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol 1991;109:77-83.
114. Sommer A, Miller NR, Pollack I. The nerve fiber layer in the diagnosis of glaucoma. Arch Ophthalmol 1977;95:2149-56.
115. Quigley HA. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am JOphthalmol 1989;107:453.
116. Wang F, Quigley HA, Tielsch JM. Screening for glaucoma in a medical clinic with photographs of the nerve fiber layer. Arch Ophthalmol 1994;112:796-800.
117. Tuulonen A, Lehtola J, Airaksinen PJ. Nerve fiber layer defects with normal visual fields. Do normal optic disc and normal visual field indicate absence of glaucomatous abnormality? Ophthalmology 1993;100:587-97 [discussion: 597-8].
118. Diggory P, Franks W. Glaucoma: systemic side effects of topical medical therapy - a common and under recognized problem [editorial]. J R Soc Med 1994;87:575-6.
119. Diggory P, Heyworth P, Chau G, McKenzie S, Sharma A. Unsuspected bronchospasm in association with topical timolol - a common problem in elderly people: can we easily identify those affected and do cardioselective agents lead to improvement? Age Ageing 1994;23:17-21.
120. Werner EB, Drance SM, Schulzer M. Trabeculectomy and the progression of glaucomatous visual field loss. Arch Ophthalmol 1977;95:1374-7.
121. Fingeret M, Kowal D. Acute glaucomas: diagnosis and treatment. Optom Clin 1991;1:165-91.